Events

Recall of CUSTOM TRILOGY STYLE ALLOFIT IT INSERTER

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by ZIMMER BIOMET CANADA INC..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    89169
  • Event Risk Class
    III
  • Event Initiated Date
    2015-11-26
  • Event Country
    Canada
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Zimmer biomet is initiating a lot specific recall of the trilogy style allofit it inserters part number 82-0174-140-00. zimmer biomet received two complaints for three devices which had bent and cracked at the weld which connects the allofit it inserter handle to the allofit it inserter tip. the affected devices were distributed between 25 june 2011 and 28 december 2012.

Device

CUSTOM TRILOGY STYLE ALLOFIT IT INSERTER
  • Model / Serial
    Model Catalog: 82-0174-140-00 (Lot serial: all lots)
  • Product Description
    CUSTOM TRILOGY STYLE ALLOFIT IT INSERTER
  • Manufacturer
    ZIMMER BIOMET CANADA INC.

Manufacturer

ZIMMER BIOMET CANADA INC.
  • Manufacturer Address
    MISSISSAUGA
  • Manufacturer Parent Company (2017)
    Zimmer Biomet Holdings
  • Manufacturer comment
    “The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.
  • Source
    HC